These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16470520)

  • 21. [Survival in adults with acute lymphoblastic leukaemia].
    Tangen JM; Fløisand Y; Haukås E; Naess IA; Skjelbakken T; Stapnes C; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1710-3. PubMed ID: 20835280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
    López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
    Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How should we treat the AYA patient with newly diagnosed ALL?
    Boissel N
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):175-183. PubMed ID: 29050690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Dana Farber Consortium Protocol for the Treatment of Adolescents and Young Adults With Acute Lymphoblastic Leukemia: A Single Institution Experience in Saudi Arabia.
    Alabdulwahab AS; Elsayed HG; Sherisher MA; Elbjeirami WM; Alieldin N
    Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):320-325. PubMed ID: 28343905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcome of adolescents with acute lymphoblastic leukemia.
    Irken G; Oren H; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Uysal K; Cevik N
    Ann Hematol; 2002 Nov; 81(11):641-5. PubMed ID: 12454702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Schrøder H; Kjeldahl M; Boesen AM; Nielsen OJ; Schmidt K; Johnsen HE; Gregersen H; Heyman M; Gustafsson G
    Dan Med Bull; 2006 Feb; 53(1):76-9. PubMed ID: 16761337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How I treat acute lymphoblastic leukemia in older adolescents and young adults.
    Curran E; Stock W
    Blood; 2015 Jun; 125(24):3702-10. PubMed ID: 25805810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
    Lukenbill J; Advani AS
    Curr Hematol Malig Rep; 2013 Jun; 8(2):91-7. PubMed ID: 23559026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adapted paediatric regimen benefits adults with ALL.
    Gilbert JA
    Lancet Oncol; 2014 Sep; 15(10):e421. PubMed ID: 25328946
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment outcome of young children with acute lymphoblastic leukaemia: achievements and directions implied from Shanghai Children's Medical Centre based SCMC-ALL-2005 protocol.
    Liang Y; Yang LH; Jiang H; Yuan XJ; Sun LR; Wang NL; Tang JY
    Br J Haematol; 2015 Apr; 169(2):267-77. PubMed ID: 25655921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
    Pinheiro Junior ED; Pracchia LF; Beitler de Mauriño B; Martinez GA; Dorlhiac-Llacer PE; Medina AB; Velloso ED
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e7-e14. PubMed ID: 25130688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
    Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL
    Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
    Ducassou S; Ferlay C; Bergeron C; Girard S; Laureys G; Pacquement H; Plantaz D; Lutz P; Vannier JP; Uyttebroeck A; Bertrand Y
    Br J Haematol; 2011 Feb; 152(4):441-51. PubMed ID: 21210776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B-cell non-Hodgkin lymphoma.
    Gupta S; Alexander S; Pole JD; Sutradhar R; Crump M; Nagamuthu C; Baxter NN; Nathan PC
    Br J Haematol; 2022 Feb; 196(3):743-752. PubMed ID: 34599525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.